These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 26837693

  • 1. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
    Bi R, Shen X, Zhang W, Cheng Y, Feng Z, Cai X, Yang W.
    Diagn Pathol; 2016 Feb 02; 11():17. PubMed ID: 26837693
    [Abstract] [Full Text] [Related]

  • 2. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL.
    Int J Clin Exp Pathol; 2015 Feb 02; 8(5):5642-9. PubMed ID: 26191276
    [Abstract] [Full Text] [Related]

  • 3. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
    Lu L, Wang S, Zhu Q, Qu Y, Gu W, Ning Y, Chen X, Wang Y.
    Pathol Res Pract; 2018 Aug 02; 214(8):1087-1094. PubMed ID: 29866423
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.
    Hsu KF, Shen MR, Huang YF, Cheng YM, Lin SH, Chow NH, Cheng SW, Chou CY, Ho CL.
    Br J Cancer; 2015 Jul 28; 113(3):414-24. PubMed ID: 26158423
    [Abstract] [Full Text] [Related]

  • 5. Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.
    Fadare O, Liang SX, Crispens MA, Jones HW, Khabele D, Gwin K, Zheng W, Mohammed K, Parkash V, Hecht JL, Desouki MM.
    Hum Pathol; 2013 Aug 28; 44(8):1508-15. PubMed ID: 23465280
    [Abstract] [Full Text] [Related]

  • 6. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.
    Mei L, Hu Q, Peng J, Ruan J, Zou J, Huang Q, Liu S, Wang H.
    Int J Clin Exp Pathol; 2015 Aug 28; 8(5):5597-602. PubMed ID: 26191270
    [Abstract] [Full Text] [Related]

  • 7. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
    Kuşku Cabuk F, Yığıt S, Demır L, Cakalağaoğlu F, Tarhan O.
    Turk Patoloji Derg; 2014 Aug 28; 30(1):30-7. PubMed ID: 24448704
    [Abstract] [Full Text] [Related]

  • 8. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.
    Köbel M, Xu H, Bourne PA, Spaulding BO, Shih IeM, Mao TL, Soslow RA, Ewanowich CA, Kalloger SE, Mehl E, Lee CH, Huntsman D, Gilks CB.
    Mod Pathol; 2009 Mar 28; 22(3):469-75. PubMed ID: 19136932
    [Abstract] [Full Text] [Related]

  • 9. IMP3 Expression in Borderline Tumors of the Ovary.
    El-Balat A, Sänger N, Karn T, Becker S, Holtrich U, Muallem Z, Arsenic R.
    Anticancer Res; 2017 Feb 28; 37(2):583-588. PubMed ID: 28179304
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Lee D, Yu EJ, Ham IH, Hur H.
    Anticancer Res; 2017 Jan 28; 37(1):135-142. PubMed ID: 28011483
    [Abstract] [Full Text] [Related]

  • 11. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
    Nguyen TM, Shin IW, Lee TJ, Park J, Kim JH, Park MS, Lee EJ.
    Gynecol Oncol; 2016 Mar 28; 140(3):545-53. PubMed ID: 26691219
    [Abstract] [Full Text] [Related]

  • 12. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
    Riener MO, Fritzsche FR, Clavien PA, Pestalozzi BC, Probst-Hensch N, Jochum W, Kristiansen G.
    Hum Pathol; 2009 Oct 28; 40(10):1377-83. PubMed ID: 19467694
    [Abstract] [Full Text] [Related]

  • 13. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F, Ding W, He JH, Wang XJ, Ma ZB, Li YF.
    BMC Cancer; 2015 Oct 20; 15():746. PubMed ID: 26487491
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
    Takizawa K, Yamamoto H, Taguchi K, Ohno S, Tokunaga E, Yamashita N, Kubo M, Nakamura M, Oda Y.
    Hum Pathol; 2016 Sep 20; 55():30-8. PubMed ID: 27137988
    [Abstract] [Full Text] [Related]

  • 15. IMP3 expression in human ovarian cancer is associated with improved survival.
    Noske A, Faggad A, Wirtz R, Darb-Esfahani S, Sehouli J, Sinn B, Nielsen FC, Weichert W, Buckendahl AC, Röske A, Müller B, Dietel M, Denkert C.
    Int J Gynecol Pathol; 2009 May 20; 28(3):203-10. PubMed ID: 19620937
    [Abstract] [Full Text] [Related]

  • 16. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L, Li HG, Xia ZS, Lü J, Peng TS.
    Chin Med J (Engl); 2010 Dec 20; 123(24):3554-8. PubMed ID: 22166630
    [Abstract] [Full Text] [Related]

  • 17. Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.
    Berntsson J, Lundgren S, Nodin B, Uhlén M, Gaber A, Jirström K.
    J Ovarian Res; 2014 Feb 26; 7():26. PubMed ID: 24568264
    [Abstract] [Full Text] [Related]

  • 18. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
    Brun JL, Cortez A, Lesieur B, Uzan S, Rouzier R, Daraï E.
    Oncol Rep; 2012 Apr 26; 27(4):1049-57. PubMed ID: 22200690
    [Abstract] [Full Text] [Related]

  • 19. Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Aman M, Ohishi Y, Imamura H, Shinozaki T, Yasutake N, Kato K, Oda Y.
    Hum Pathol; 2017 Jun 26; 64():156-163. PubMed ID: 28438620
    [Abstract] [Full Text] [Related]

  • 20. The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis.
    Chen LT, Lin LJ, Zheng LL.
    Hepatogastroenterology; 2013 May 26; 60(123):553-6. PubMed ID: 23159356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.